Evidence map›Paper›PMID 34060721›Full record

ArticlePediatric blood & cancer2021

A pediatric COVID hematology/oncology ward to guarantee adequate medical and nursing assistance.

Matteo Amicucci, Federica Perigli, Giuliana D'Elpidio, Adele Ripà, Angela Mastronuzzi, Maria Antonietta De Ioris, Andreea Cristina Schiopu, Immacolata Dall'Oglio, Italo Ciaralli

Abstract read
In one paragraph

Article in Pediatric blood & cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matteo AmicucciDepartment of Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0003-2025-9741
Federica PerigliDepartment of Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Giuliana D'ElpidioUniversity of Rome "Tor Vergata," Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
Adele RipàDepartment of Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Angela MastronuzziDepartment of Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Maria Antonietta De IorisDepartment of Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-2113-4505
Andreea Cristina SchiopuDepartment of Paediatric Emergency, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Immacolata Dall'OglioProfessional Development, Continuing Education and Nursing Research Service, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Italo CiaralliDepartment of Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HematologyMedical OncologyChildHumansSARS-CoV-2

Identifiers

PMID34060721
PMCPMC8209815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.